Probiotics, particularly strains of Bifidobacterium animalis subsp. lactis, show some evidence of improving digestive comfort and gastrointestinal symptoms in adults without diagnosed GI disorders. Evidence for other gut health benefits across various conditions is limited or uncertain.
High-quality evidence from randomized controlled trials and systematic reviews indicates that fermented milk containing Bifidobacterium animalis subsp. lactis can improve digestive comfort and reduce digestive symptoms in adults with minor digestive complaints. Meta-analyses and systematic reviews in other populations, such as solid organ transplant recipients and chronic kidney disease patients, show very low certainty evidence and no clear benefits of synbiotics, prebiotics, or probiotics on gut health outcomes. Evidence for probiotic support improving cognitive function in Alzheimer's disease is promising but requires further high-quality studies. In children and adolescents with neuropsychiatric disorders, Bifidobacterium supplementation shows potential but evidence is limited. Gut microbiome-based interventions for obesity in children and adolescents show very low certainty evidence with minimal effects. Probiotic interventions with Lactobacillus in liver transplant patients have not demonstrated clear benefits in preventing infections or complications. Overall, safety profiles are good with minimal adverse events reported. More rigorous, strain-specific, and adequately powered studies are needed to confirm benefits and clarify effective strains and populations.
Evidence is strongest for digestive comfort in adults without diagnosed GI disorders; effects in other populations or conditions are less certain.
No specific strain identified; benefits uncertain and further research needed.
Strain-specific effects not well defined; more research needed.
Probiotic and synbiotic interventions are generally safe with minimal and mild adverse events reported, such as flatulence, nausea, diarrhea, abdominal pain, and mild digestive discomfort. No serious adverse events related to probiotic use were reported in the reviewed studies.
Most studies have small sample sizes, short durations, and heterogeneous interventions. Many systematic reviews report very low certainty evidence due to risk of bias, unclear strain identification, and inconsistent outcomes. There is a lack of high-quality, adequately powered randomized controlled trials with standardized probiotic strains and doses. Evidence is often mixed or uncertain, especially in populations with chronic diseases or complex conditions. More research is needed to clarify strain-specific effects and long-term benefits.
Probiotics.info is an educational and research platform. Its content does not constitute medical advice.
By continuing, you acknowledge our policies and agree to our Terms of Use.
Necessary cookies keep the website working. You can also allow optional cookies for analytics and referral tracking.
You can change your cookie preferences later.